A Risk Factor Analysis of Donor-Specific Factors on One- and Three-Year Post-Transplant Mortality After Multi Visceral Transplantation

被引:0
|
作者
Ivanics, T. [1 ]
Jafri, S. [2 ]
Muszkat, Y. [3 ]
Rizzari, M. [4 ]
Abouljoud, M. [5 ]
Yoshida, A. [6 ]
Nagai, S. [5 ]
机构
[1] Henry Ford Hosp, Surg, Detroit, MI USA
[2] Henry Ford Hlth Syst, Detroit, MI USA
[3] Henry Ford Hosp, Div Gastroenterol & Hepatol, Detroit, MI USA
[4] Henry Ford Hosp, Div Transplant & Hepatobiliary Surg, Detroit, MI USA
[5] Henry Ford Transplant Inst, Detroit, MI USA
[6] Henry Ford Hosp, Grosse Pointe, MI USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
337
引用
收藏
页码:S503 / S503
页数:1
相关论文
共 27 条
  • [21] RISK FACTORS OF EPSTEIN-BARR VIRUS REACTIVATION AND POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION: RESULTS FROM A LARGE MULTICENTRE STUDY
    Blazquez-Navarro, A.
    Dang-Heine, C.
    Bauer, C.
    Wittenbrink, N.
    Wolk, K.
    Sabat, R.
    Westhoff, T. H.
    Sawitzki, B.
    Viebahn, R.
    Reinke, P.
    Or-Guil, M.
    Thomusch, O.
    Hugo, C.
    Babel, N.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 22 - 22
  • [22] Incidence and Risk Factors of CMV Reactivation after Haploidentical Hematopoietic Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide - Possible Role of Donor KIR Genotypes
    Al Malki, Monzr
    Dadwal, Sanjeet
    Yang, Dongyun
    Mokhtari, Sally
    Cao, Thai
    Gendzekhadze, Ketevan
    Snyder, David S.
    Ali, Haris
    Aldoss, Ibrahim
    Salhotra, Amandeep
    Marcucci, Guido
    Karanes, Chatchada
    Parker, Pablo
    Nademanee, Auayporn P.
    Diamond, Don
    Zaia, John
    Forman, Stephen J.
    Nakamura, Ryotaro
    BLOOD, 2018, 132
  • [23] Epstein-Barr Virus reactivation and post-transplant lymphoproliferative disease: risk factor analysis and impact on overall survival after high-risk allogeneic stem cell transplantation
    Garcia-Cadenas, I.
    Castillo, N.
    Esquirol, A.
    Barba, P.
    Martino, R.
    Brunet, S.
    Briones, J.
    Rabella, N.
    Ruiz, I.
    Valcarcel, D.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S320 - S320
  • [24] Post-Transplant Malignancy after Pediatric Kidney Transplantation: Retrospective Analysis of Incidence and Risk Factors in 884 Patients Receiving Transplants Between 1963 and 2015 at the University of Minnesota
    Serrano, Oscar K.
    Bangdiwala, Ananta S.
    Vock, David M.
    Chinnakotla, Srinath
    Dunn, Ty B.
    Finger, Erik B.
    Kandaswamy, Raja
    Pruett, Timothy L.
    Najarian, John S.
    Matas, Arthur J.
    Chavers, Blanche M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (02) : 181 - 193
  • [25] "Post-transplant lymphoproliferative disorders following kidney transplantation: A literature review with updates on risk factors, prognostic indices, screening strategies, treatment and analysis of donor type " (vol 38, 100837, 2024)
    Ergisi, Mehmet
    Ooi, Bryan
    Salim, Omar
    Papalois, Vassilios
    TRANSPLANTATION REVIEWS, 2024, 38 (02)
  • [26] Veno-occlusive disease of the liver after blood and marrow transplantation:: Analysis of pre- and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator
    Litzow, MR
    Repoussis, PD
    Schroeder, G
    Schembri-Wismayer, D
    Batts, KP
    Anderson, PM
    Arndt, CAS
    Chen, MG
    Gastineau, DA
    Gertz, MA
    Inwards, DJ
    Lacy, MQ
    Tefferi, A
    Noël, P
    Solberg, LA
    Letendre, L
    Hoagland, HC
    LEUKEMIA & LYMPHOMA, 2002, 43 (11) : 2099 - 2107
  • [27] Lower Risk of One-Year Non-Relapse Mortality, Rapid Engraftment and Better NK Cell Recovery with GvHD Prophylaxis Based in Post-Transplant Cyclophosphamide/Bendamustine in Pediatric Hematopoietic Stem Cell Transplantation
    Ramirez, Oscar
    Portilla, Carlos Andres
    Buitrago, Jorge Luis
    Lopez, Eduardo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)